News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

September

22

TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization

WESTMINSTER, Colo.–(BUSINESS WIRE)–Sep. 22, 2026– TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an...